125 related articles for article (PubMed ID: 21518525)
1. [Effect of GDF15 on iron overloading and erythropoiesis].
Zhao YS; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):537-41. PubMed ID: 21518525
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 15 in erythroid health and disease.
Tanno T; Noel P; Miller JL
Curr Opin Hematol; 2010 May; 17(3):184-90. PubMed ID: 20182355
[TBL] [Abstract][Full Text] [Related]
3. Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.
Finkenstedt A; Bianchi P; Theurl I; Vogel W; Witcher DR; Wroblewski VJ; Murphy AT; Zanella A; Zoller H
Br J Haematol; 2009 Mar; 144(5):789-93. PubMed ID: 19120353
[TBL] [Abstract][Full Text] [Related]
4. GDF15 expression and iron overload in ineffective erythropoiesis.
Tanno T; Miller JL
Rinsho Ketsueki; 2011 Jun; 52(6):387-98. PubMed ID: 21737991
[No Abstract] [Full Text] [Related]
5. The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients.
Youssry I; Samy RM; AbdelMohsen M; Salama NM
Pediatr Res; 2024 Mar; 95(4):1095-1100. PubMed ID: 37464096
[TBL] [Abstract][Full Text] [Related]
6. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
Tanno T; Bhanu NV; Oneal PA; Goh SH; Staker P; Lee YT; Moroney JW; Reed CH; Luban NL; Wang RH; Eling TE; Childs R; Ganz T; Leitman SF; Fucharoen S; Miller JL
Nat Med; 2007 Sep; 13(9):1096-101. PubMed ID: 17721544
[TBL] [Abstract][Full Text] [Related]
7. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
Cui R; Gale RP; Zhu G; Xu Z; Qin T; Zhang Y; Huang G; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Leuk Res; 2014 May; 38(5):545-50. PubMed ID: 24598841
[TBL] [Abstract][Full Text] [Related]
8. Gdf15 regulates murine stress erythroid progenitor proliferation and the development of the stress erythropoiesis niche.
Hao S; Xiang J; Wu DC; Fraser JW; Ruan B; Cai J; Patterson AD; Lai ZC; Paulson RF
Blood Adv; 2019 Jul; 3(14):2205-2217. PubMed ID: 31324641
[TBL] [Abstract][Full Text] [Related]
9. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
[No Abstract] [Full Text] [Related]
10. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.
Tamary H; Shalev H; Perez-Avraham G; Zoldan M; Levi I; Swinkels DW; Tanno T; Miller JL
Blood; 2008 Dec; 112(13):5241-4. PubMed ID: 18824595
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.
Theurl I; Finkenstedt A; Schroll A; Nairz M; Sonnweber T; Bellmann-Weiler R; Theurl M; Seifert M; Wroblewski VJ; Murphy AT; Witcher D; Zoller H; Weiss G
Br J Haematol; 2010 Feb; 148(3):449-55. PubMed ID: 19863534
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
[TBL] [Abstract][Full Text] [Related]
13. The role of hepcidin, GDF15, and mitoferrin-1 in iron metabolism of polycythemia vera and essential thrombocytosis patients.
Albayrak C; Tarkun P; Birtaş Ateşoğlu E; Eraldemir C; Özsoy ÖD; Terzi Demirsoy E; Mehtap Ö; Gedük A; Hacıhanefioğlu A
Turk J Med Sci; 2019 Feb; 49(1):74-80. PubMed ID: 30761871
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II.
Casanovas G; Swinkels DW; Altamura S; Schwarz K; Laarakkers CM; Gross HJ; Wiesneth M; Heimpel H; Muckenthaler MU
J Mol Med (Berl); 2011 Aug; 89(8):811-6. PubMed ID: 21475976
[TBL] [Abstract][Full Text] [Related]
15. GDF15 is related to anemia and hepcidin in kidney allograft recipients.
Malyszko J; Koc-Zorawska E; Malyszko JS; Glowinska I; Mysliwiec M; Macdougall IC
Nephron Clin Pract; 2013; 123(1-2):112-7. PubMed ID: 23797049
[TBL] [Abstract][Full Text] [Related]
16. GDF15-mediated upregulation of ferroportin plays a key role in the development of hyperferritinemia in children with hemophagocytic lymphohistiocytosis.
Wu JR; Yuan LX; Ma ZG; Chen XX; Gu L; Gao J
Pediatr Blood Cancer; 2013 Jun; 60(6):940-5. PubMed ID: 23335088
[TBL] [Abstract][Full Text] [Related]
17. New insights into iron regulation and erythropoiesis.
Kim A; Nemeth E
Curr Opin Hematol; 2015 May; 22(3):199-205. PubMed ID: 25710710
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts.
Ramirez JM; Schaad O; Durual S; Cossali D; Docquier M; Beris P; Descombes P; Matthes T
Br J Haematol; 2009 Jan; 144(2):251-62. PubMed ID: 19036111
[TBL] [Abstract][Full Text] [Related]
19. Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia.
Origa R; Cazzola M; Mereu E; Danjou F; Barella S; Giagu N; Galanello R; Swinkels DW
Haematologica; 2015 May; 100(5):e169-71. PubMed ID: 25596269
[No Abstract] [Full Text] [Related]
20. Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression.
Frazer DM; Wilkins SJ; Darshan D; Badrick AC; McLaren GD; Anderson GJ
Br J Haematol; 2012 Jun; 157(5):615-26. PubMed ID: 22449175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
